Gillian Woollett
10PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Jul 17, 2025
Analytical Data and Single-Dose PK are Sufficient to Conclude Comparable Immunogenicity for Biosimilars: An Ustekinumab Case Study.Martin Schiestl, Nivedita Roy, Michael Trieb
|Aug 05, 2023
Future Evolution of Biosimilar Development by Application of Current Science and Available Evidence: The Developer's Perspective.Hillel P Cohen, Matthew Turner, Dorothy McCabe
|Sep 23, 2022
The Role of PD Biomarkers in Biosimilar Development - To Get the Right Answer One Must First Ask the Right Question.Gillian R Woollett, Joseph P Park, Jihyun Han
|Jun 18, 2021
Comparability of Biologics: Global Principles, Evidentiary Consistency and Unrealized Reliance.Christopher J Webster, Kelly L George, Gillian R Woollett
|Aug 08, 2019
An Efficient Development Paradigm for Biosimilars.Christopher J Webster, Anny C Wong, Gillian R Woollett
|Aug 08, 2019
Insulins as Drugs or Biologics in the USA: What Difference Does it Make and Why Does it Matter?Kelly George, Gillian Woollett
Pageof 2
